Dr. Zeevi received her DVM from the Koret School of Veterinary Medicine, The Hebrew University of Jerusalem and her PhD in microbiology and immunology from the Beer Sheva University. Her roles at NeuroDerm involve leading all internal, out-sourced, and collaborative research activities for the company. These activities include directing and coordinating formulation, optimization, and product development, overseeing analytical and bio-analytical methods, and creating testing for in vitro and in vivo models for the evaluation of safety and efficacy. Dr. Zeevi has over 20 yrs experience in designing and directing research and pharmaceutical development programs. This experience includes GLP-compliant pre-clinical development of small molecule and biological drugs in various indications – including CNS diseases – for the pharmaceutical and biotech industry. She holds 14 patents and patent applications for her inventions, the latest of which forms the basis of NeuroDerm’s current project, ND0611.
Associated Grants
-
Maintenance of Continuous Plasma Levodopa Levels through Continuous Subcutaneous Carbidopa Administration
2010